1. Renal denervation prevents myocardial structural remodeling and arrhythmogenicity in a chronic kidney disease rabbit model
- Author
-
Wen Han Cheng, Wei Lun Lin, Yu Hui Chou, Tseng Ying Tsai, Shih Ann Chen, Shinya Yamada, Li Wei Lo, and Shin Huei Liu
- Subjects
medicine.medical_specialty ,Heart Ventricles ,medicine.medical_treatment ,030204 cardiovascular system & hematology ,Kidney ,urologic and male genital diseases ,03 medical and health sciences ,Renal Artery ,0302 clinical medicine ,Physiology (medical) ,medicine.artery ,Internal medicine ,Neuromodulation ,Autonomic Denervation ,medicine ,Animals ,030212 general & internal medicine ,Renal Insufficiency, Chronic ,Renal artery ,Denervation ,Ventricular Remodeling ,business.industry ,Arrhythmias, Cardiac ,Atrial Remodeling ,medicine.disease ,Fibrosis ,female genital diseases and pregnancy complications ,Nephrectomy ,Treatment Outcome ,medicine.anatomical_structure ,Models, Animal ,Catecholamine ,Cardiology ,Immunohistochemistry ,Myocardial fibrosis ,Rabbits ,Cardiomyopathies ,Electrophysiologic Techniques, Cardiac ,Cardiology and Cardiovascular Medicine ,business ,Kidney disease ,medicine.drug - Abstract
The electrophysiological (EP) effects and safety of renal artery denervation (RDN) in chronic kidney disease (CKD) are unclear.The purpose of this study was to investigate the arrhythmogenicity of RDN in a rabbit model of CKD.Eighteen New Zealand white rabbits were randomized to control (n = 6), CKD (n = 6), and CKD-RDN (n = 6) groups. A 5/6 nephrectomy was selected for the CKD model. RDN was applied in the CKD-RDN group. All rabbits underwent cardiac EP studies for evaluation. Immunohistochemistry, myocardial fibrosis, and renal catecholamine levels were evaluated.The CKD group (34.8% ± 9.2%) had a significantly higher ventricular arrhythmia (VA) inducibility than the control (8.6% ± 3.8%; P.01) and CKD-RDN (19.5% ± 6.3%; P = .01) groups. In the CKD-RDN group, ventricular fibrosis was significantly decreased compared to the CKD group (7.4% ± 2.0 % vs 10.4% ± 3.7%; P = .02). Sympathetic innervation in the CKD group was significantly increased compared to the control and CKD-RDN groups [left ventricle: 4.1 ± 1.8 vs 0.8 ± 0.5 (10Neuromodulation by RDN demonstrated protective effects with less structural and electrical remodeling, leading to attenuated VAs. In a rabbit model of CKD, RDN plays a therapeutic role by lowering the risk of VA caused by autonomic dysfunction.
- Published
- 2021
- Full Text
- View/download PDF